Welcome to Novanex. We are a US-based medical device company that develops and commercializes innovative technologies to monitor and detect disease conditions and status.

Our first product, currently undergoing clinical testing, is the NV100, a noninvasive blood glucose monitor designed to bring relief to the millions of diabetic patients who would rather not have to draw frequent blood samples. It monitors and displays blood glucose level in two minutes, and is designed for use in hospitals as well as in outpatient sites and homes.

NV100 is in the process of US regulatory filing, and has been tested with high reliability and accuracy in several studies. Results indicate NV100 performance similar to that of invasive glucose sensors on the market today. Our products are based on our proprietary, patented Optimized Metabolic Calorimetry technology, which overcomes critical obstacles that hinder the performance of many competing approaches.

Novanex is now designing the software and hardware for the NV200 prototype, which will connect to a smartphone via Bluetooth, uploading data to the cloud for easy access by both doctor and patient.

Novanex has been granted a U.S. patent to protect its novel device, method, and algorithm.